Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion

Surgery

Volumn 130, Issue 2, 2001, Pages 230-235

  Cassada, David C ^a   Tribble, Curtis G ^a   Kaza, Aditya K ^a   Fiser, Steven M ^a   Long, Stewart M ^a   Linden, Joel ^a   Rieger, Jayson M ^a   Kron, Irving L ^a   Kern, John A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDROFURAN 2 YL) 9H PURIN 2 YL]PROP 2 YNYL]CYCLOHEXANE CARBOXYLIC ACID METHYL ESTER; ADENOSINE A2 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SPINAL CORD INJURY; TIME; TREATMENT OUTCOME;

EID: 0034896892     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.115838     Document Type: Article

References (25)

1. Thoracoabdominal aneurysm repair: A representative experience
2. Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients
3. Preservation of intercostal arteries during thoracoabdominal aortic aneurysm surgery: A retrospective study
4. Moderate hypothermia, with partial bypass and segmental sequential repair for thoracoabdominal aortic aneurysm
5. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine
6. Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model
7. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion
8. Adenosine and selective A2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibition leukocyte activation
9. Design, synthesis, and evaluation of novel adenosine A2A receptor agonists
10. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propunylcyclohexyl adenosine A2A receptor agonists
11. Changes in cerebrospinal fluid pressure and spinal cord perfusion pressure prior to cross-clamping of the thoracic aorta in humans
12. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release
13. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells: Cross-talk between cyclic AMP and protein kinase c pathways
14. Adenosine, an endogenous anti-inflammatory agent
15. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection
16. A physiological role of the adenosine A3 receptor: Sustained cardioprotection
17. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
18. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively
19. Propentofylline enhancement of the actions of adenosine on neutrophil leukocytes
20. The role of inflammation in vascular diseases
21. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells
22. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes
23. Fas receptor and neuronal cell death after spinal cord ischemia
24. Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits
25. Regarding "Observations on delayed neurologic deficit after thoracoabdominal aortic aneurysm"